Cargando…
Reply: Roll out of bedaquiline without drug susceptibility testing leads to emergence of bedaquiline-resistance in high burden countries with tuberculosis - Danger of losing a novel drug
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390310/ https://www.ncbi.nlm.nih.gov/pubmed/35848680 http://dx.doi.org/10.4103/lungindia.lungindia_31_22 |
| _version_ | 1784770625895661568 |
|---|---|
| author | Jain, Nirmal Kumar |
| author_facet | Jain, Nirmal Kumar |
| author_sort | Jain, Nirmal Kumar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9390310 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93903102022-08-20 Reply: Roll out of bedaquiline without drug susceptibility testing leads to emergence of bedaquiline-resistance in high burden countries with tuberculosis - Danger of losing a novel drug Jain, Nirmal Kumar Lung India Correspondence Wolters Kluwer - Medknow 2022 2022-07-01 /pmc/articles/PMC9390310/ /pubmed/35848680 http://dx.doi.org/10.4103/lungindia.lungindia_31_22 Text en Copyright: © 2022 Indian Chest Society https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Correspondence Jain, Nirmal Kumar Reply: Roll out of bedaquiline without drug susceptibility testing leads to emergence of bedaquiline-resistance in high burden countries with tuberculosis - Danger of losing a novel drug |
| title | Reply: Roll out of bedaquiline without drug susceptibility testing leads to emergence of bedaquiline-resistance in high burden countries with tuberculosis - Danger of losing a novel drug |
| title_full | Reply: Roll out of bedaquiline without drug susceptibility testing leads to emergence of bedaquiline-resistance in high burden countries with tuberculosis - Danger of losing a novel drug |
| title_fullStr | Reply: Roll out of bedaquiline without drug susceptibility testing leads to emergence of bedaquiline-resistance in high burden countries with tuberculosis - Danger of losing a novel drug |
| title_full_unstemmed | Reply: Roll out of bedaquiline without drug susceptibility testing leads to emergence of bedaquiline-resistance in high burden countries with tuberculosis - Danger of losing a novel drug |
| title_short | Reply: Roll out of bedaquiline without drug susceptibility testing leads to emergence of bedaquiline-resistance in high burden countries with tuberculosis - Danger of losing a novel drug |
| title_sort | reply: roll out of bedaquiline without drug susceptibility testing leads to emergence of bedaquiline-resistance in high burden countries with tuberculosis - danger of losing a novel drug |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390310/ https://www.ncbi.nlm.nih.gov/pubmed/35848680 http://dx.doi.org/10.4103/lungindia.lungindia_31_22 |
| work_keys_str_mv | AT jainnirmalkumar replyrolloutofbedaquilinewithoutdrugsusceptibilitytestingleadstoemergenceofbedaquilineresistanceinhighburdencountrieswithtuberculosisdangeroflosinganoveldrug |